Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
0.6469
-0.2681 (-29.30%)
At close: Sep 17, 2025, 4:00 PM EDT
0.6400
-0.0069 (-1.07%)
After-hours: Sep 17, 2025, 7:59 PM EDT

Enveric Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
24342911,306
Upgrade
Market Cap Growth
-38.39%20.78%-30.19%-85.19%-99.74%-
Upgrade
Enterprise Value
-11-1-16811,308
Upgrade
Last Close Price
0.655.3819.5031.20697.503195.00
Upgrade
PB Ratio
0.902.291.540.281.313309.96
Upgrade
P/TBV Ratio
0.962.351.730.302.127223.28
Upgrade
Debt / Equity Ratio
0.05--0.000.01-
Upgrade
Quick Ratio
2.091.501.074.438.332.32
Upgrade
Current Ratio
2.421.841.534.618.513.35
Upgrade
Return on Equity (ROE)
-261.96%-539.57%-197.47%-97.57%-380.82%-855.92%
Upgrade
Return on Assets (ROA)
-129.73%-163.09%-86.20%-53.92%-102.60%-166.96%
Upgrade
Return on Capital (ROIC)
-161.94%-339.25%-116.97%-65.48%-122.09%-299.51%
Upgrade
Earnings Yield
-473.46%-262.70%-573.01%-427.30%-167.81%-0.06%
Upgrade
FCF Yield
-310.49%-211.97%-467.23%-410.17%-39.91%-0.03%
Upgrade
Buyback Yield / Dilution
-425.68%-249.39%-49.31%-206.13%--
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q